Skip to main content
. Author manuscript; available in PMC: 2021 May 25.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2018 Aug 29;18(12):788–795.e2. doi: 10.1016/j.clml.2018.08.009

Figure 1.

Figure 1

IRB-Approved Study Sites Participating in REVEAL. A Total of 2510 Patients Were Enrolled From 227 Sites Across the United States (39 Academic and 188 Community [Self-identified])

Abbreviations: IRB = institutional review board; REVEAL = Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices.